Tuesday, December 4, 2018

Genetically engineered immune cells show promise for fighting relapsed blood cancer

Researchers are presenting preliminary results from a clinical study of an investigational cellular immunotherapy for Hodgkin lymphoma and non-Hodgkin lymphoma expressing the CD30 protein marker.

from Latest Science News -- ScienceDaily https://ift.tt/2RxWVXo
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Gas stoves are filling millions of homes with hidden toxic air

Stanford researchers found that gas stoves expose Americans to surprisingly high levels of nitrogen dioxide—often matching or exceeding outd...